期刊文献+

结核潜伏感染动物模型的研究进展 被引量:1

Progress in animal models of latent tuberculosis infection
下载PDF
导出
摘要 结核潜伏感染(latent tuberculosis infection,LTBI)是机体对结核分枝杆菌抗原持续性免疫反应的状态,既无活动性结核病临床症状,也无结核病影像学表现。LTBI激活是新发结核病的主要来源之一。LTBI动物模型的建立是研究结核的潜伏感染和复发机制,开发诊断试剂,评估抗结核新药、新疫苗的有效性、安全性的基础。建立稳定、成本低、易推广、潜伏期时长适中、复发起点和复发水平变异小的LTBI动物模型,是其未来研究发展的方向。本文就LTBI动物模型的研究进展进行综述,期望为结核病防治工作者提供参考资料。 Latent tuberculosis infection(LTBI)is a state of persistent immune response to Mycobacterium tuberculosis antigen without clinical symptoms or imaging findings of active tuberculosis.The relapse of LTBI is one of the main sources of active tuberculosis.Generating an LTBI animal model is the foundation for studying mechanisms of latency and recurrence of tuberculosis infection,developing diagnostic reagents,and assessing the efficacy and safety about new anti-tuberculosis drugs and vaccines.Developing an LTBI animal model with consistent phenotype,low cost,easy to master and popularize,suitable length of time of latent period,small variation in relapse threshold and relapse level would be the future direction for LTBI related studies.This review summarizes the researches on animal models of LTBI,with the hope of providing reference for those who are engaged in tuberculosis control.
作者 马嘉烨 徐进川 晏博 卢水华 MA Jiaye;XU Jinchuan;YAN Bo;LU Shuihua(Tuberculosis Research Center,Shanghai Public Health Clinical Center,Fudan University,Shanghai 201508,China)
出处 《微生物与感染》 CAS 2021年第5期363-372,共10页 Journal of Microbes and Infections
基金 国家自然科学基金(81770011、81801977)。
关键词 结核分枝杆菌 结核潜伏感染 动物模型 Mycobacterium tuberculosis Latent tuberculosis infection Animal model
  • 相关文献

参考文献2

二级参考文献27

  • 1黎友伦,王国治,罗永艾.结核分枝杆菌潜伏感染动物模型及评价[J].中华结核和呼吸杂志,2005,28(8):552-554. 被引量:17
  • 2Mu(n)oz-Elías EJ,Timm J,Botha T,et al.Replication dynamics of Mycobacterium tuberculosis in chronically infected mice.Infect Immun,2005,73:546-551.
  • 3Botha T,Reffel B.Reactivation of latent tuberculosis by an inhibitor of inducible nitric oxide synthase in an aerosol murine model.Immunology,2002,107:350-357.
  • 4Botha T,Ryffel B.Reactivation of latent tuberculosis infection in TNF-deficient mice.J Immunol,2003,171:3110-3118.
  • 5Shoen CM,DeStefano MS,Cynamon MH.Durable cure for tuberculosis:rifalazil in combination with isoniazid in a murine model of Mycobacterium tuberculosis infection.Clin Infect Dis,2000,30 Suppl 3:S288-S290.
  • 6World Health Organization. Global Tuberculosis Report 2013[M].Ge-neva:WHO,2013.
  • 7Kaufmann SH. Future vaccination strategies against tuberculosis:thinking outside the box[J].{H}IMMUNITY,2010,(04):567-577.
  • 8Ottenhoff TH,Kaufmann SH. Vaccines against tuberculosis:where are we and where do we need to go[J].{H}PLoS Pathogens,2012,(05):e1002607.
  • 9Stop TB Partnership. Tuberculosis vaccine candidates[OL].http://www.stoptb.org/wg/new_vaccines/docu-ments.asp,2013.
  • 10Aagaard C,Hoang T,Dietrich J. A multistage tuberculosis vaccine that confers efficient protection before and after exposure[J].{H}Nature Medicine,2011,(02):189-194.

共引文献12

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部